Clinical trial
The Intra-Drug Eluting Stent (DES) Restenosis Study
NCT00323895 · Cordis US Corp., Industry · Completed
Key facts
| NCT number | NCT00323895 |
|---|---|
| Title | The Intra-Drug Eluting Stent (DES) Restenosis Study |
| Official title | A Prospective, Randomized, Multi-Center Comparison of the CYPHER Select™ Sirolimus-Eluting Stent and Balloon Re-Angioplasty for Treatment of Patients With Intra-Des Restenosis |
| Acronym | CRISTAL |
| Lead sponsor | Cordis US Corp., Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Coronary Artery Disease |
| Intervention type | Device |
| Interventions | drug-eluting stent and balloon angioplasty, drug-eluting stent |
| Enrollment | 320 |
| Start date | Mar 1, 2006 |
| Primary completion | Jan 1, 2010 |
| Completion | Jan 1, 2010 |
| First posted | May 10, 2006 |
| Last update posted | Jul 29, 2010 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: